Title | Clinical and Biological Basis of Lung Cancer Prevention [electronic resource] / edited by Yves Martinet, Fred R. Hirsch, Nadine Martinet, Jean-Michel Vignaud, James L. Mulshine |
---|---|
Imprint | Basel : Birkhรคuser Basel : Imprint: Birkhรคuser, 1998 |
Connect to | http://dx.doi.org/10.1007/978-3-0348-8924-7 |
Descript | XVIII, 326 p. online resource |
1. Prevention and Early Detection of Lung Cancer โ Clinical Aspects -- 2. Smoking Prevention and Cessation -- 3. Clinical Pharmacology of Vitamin A and Retinoids -- 4. Early Lung Cancer Detection -- 5. Molecular Abnormalities in the Sequential Development of Lung Carcinoma -- 6. Application of In Situ PCR and In Situ Hybridization to the Characterization of Lung Cancers -- 7. Tumor Stroma Formation in Lung Cancer -- 8. Tumor Angiogenesis: Basis for New Prognostic Factors and New Anticancer Therapies -- 9. Cell Cycle Regulators and Mechanisms of Growth Control Evasion in Lung Cancer -- 10. Molecular Genetics of Lung Cancer -- 11. Neuropeptides, Signal Transduction and Small Cell Lung Cancer -- 12. In Vitro Analysis of Bombesin/Gastrin-Releasing Peptide Receptor (bb2) Ligand Binding and G-Protein Coupling -- 13. DNA Methylation Changes in Lung Cancer -- 14. K-ras Mutations as Molecular Markers of Lung Cancer -- 15. Sheep Lung Adenomatosis: A Model of Virally Induced Lung Cancer -- 16. Retinoic Acid Receptor ร: An Exploration of its Role in Lung Cancer Suppression and its Potential in Cancer Prevention -- 17. Cytochrome P450 Polymorphisms: Risk Factors for Lung Cancer? -- 18. Glutathione S-Transferases and Lung Cancer Risk -- 19. The p53 Tumor Suppressor Gene in Lung Cancer: From Molecular to Serological Diagnosis -- 20. Endoscopic Localization of Preneoplastic Lung Lesions -- 21. Antigen Retrieval Improves hnRNP A2/B1 Immunohisto-chemical Localization in Premalignant Lesions of the Lung -- 22. Molecular Pathological Mechanisms in NSCLC and the Assessment of Individuals with a High Risk of Developing Lung Cancer -- 23. Chemoprevention of Lung Cancer -- 24. Regional Delivery of Retinoids: A New Approach to Early Lung Cancer Intervention -- 25. Natural Inhibitors of Carcinogenesis -- 26. Gene Delivery to Airways -- 27. Lung Cancer Prevention: The Point of View of a Public Health Epidemiologist -- 28. Biomarkers as Intermediate Endpoints in Chemoprevention Trials: Biological Basis of Lung Cancer Prevention -- 29. Biological Tools for Mass Screening -- 30. Optimization of the Use of Biological Samples for the Prospective Evaluation of Preneoplastic Lesions